Skip to main content
. 2021 Oct 21;10(21):4828. doi: 10.3390/jcm10214828

Figure 2.

Figure 2

Evaluation of forced vital capacity (% of predicted) in upright position in patients with late-onset Pompe disease on enzyme replacement therapy with alglucosidase alfa. Weights are inverse-variance weights and are proportional to the contribution of each study to the summary estimate. I2 is the fraction of variance that is due to statistical heterogeneity and not chance. Tau2 denotes the between-study variance.